

1,401,945 filings since 2004 · latest accepted Nov 4, 2026, 6:10 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Jul 31, 2026 accepted 4:44 PM ET | ATYRaTYR PHARMA INC | 1.02Agreement terminated | DocumentSEC ↗ |
Jun 8, 2026 accepted 4:04 PM ET | ATYRaTYR PHARMA INC | 3.01Delisting notice | Document |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
Dec 5, 2025 accepted 4:05 PM ET | ATYRaTYR PHARMA INC | 3.01Delisting notice | DocumentSEC ↗ |
Aug 7, 2025 accepted 4:03 PM ET | ATYRaTYR PHARMA INC | 2.06Impairment | DocumentSEC ↗ |
Apr 22, 2022 accepted 5:07 PM ET | ATYRaTYR PHARMA INC | 1.01Material agreement1.02Agreement terminated | DocumentSEC ↗ |
Feb 8, 2019 accepted 4:05 PM ET | ATYRaTYR PHARMA INC | 3.01Delisting notice | DocumentSEC ↗ |
Aug 14, 2018 accepted 4:10 PM ET | ATYRaTYR PHARMA INC | 2.02Earnings release3.01Delisting notice | DocumentSEC ↗ |
May 14, 2018 accepted 6:45 AM ET | ATYRaTYR PHARMA INC | 1.02Agreement terminated2.02Earnings release2.05Restructuring costs | DocumentSEC ↗ |
Nov 21, 2016 accepted 8:00 AM ET | ATYRaTYR PHARMA INC | 1.01Material agreement1.02Agreement terminated2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |